Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension

Circulation Journal

Volumn 75, Issue 2, 2011, Pages 237-245

  Yogi, Alvaro ^a   Callera, Glaucia E ^a   Antunes, Tayze T ^a   Tostes, Rita C ^b   Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular system; Hypertension; Magnesium; TRPM7

Indexed keywords

ALDOSTERONE; ANTIPORTER; CALCINEURIN INHIBITOR; CETUXIMAB; CLAUDIN 16; DIURETIC AGENT; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MAGNESIUM; MAGNESIUM SODIUM EXCHANGE PROTEIN; SPIRONOLACTONE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; ENDOTHELIAL DYSFUNCTION; EXCITATION CONTRACTION COUPLING; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOMAGNESEMIA; MAGNESIUM DEFICIENCY; MAGNESIUM METABOLISM; MEMBRANE POTENTIAL; MEMBRANE TRANSPORT; OLIGOMERIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION;

ANNEXIN A1; CALPAIN; HOMEOSTASIS; HUMANS; HYPERTENSION; ION TRANSPORT; MAGNESIUM; MODELS, CARDIOVASCULAR; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NONMUSCLE MYOSIN TYPE IIA; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TRPM CATION CHANNELS; VASCULAR RESISTANCE; VASODILATION;

EID: 79251544571     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1021     Document Type: Review

References (126)

1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369.
2. Anderson GF, Chu E. Expanding priorities-confronting chronic disease in countries with low income. N Engl J Med 2007; 356: 209-211.
3. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cations in essential hypertension: Relations between serum ionized calcium, magnesium, and plasma rennin activity. N Engl J Med 1983; 309: 888-891.
4. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity: A nuclear magnetic resonance spectroscopic study. Hyper tension 1991; 17: 951-957.
5. Resnick LM. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 1992; 93: 11S-20S.
6. Aviv A. Salt consumption, reactive oxygen species and cardiovascular ageing: A hypothetical link. J Hypertens 2002; 20: 555-559.
7. Schiffrin EL, Touyz RM. From bedside to bench to bedside: Role of reninangiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004; 287: H435-H446.
8. Wolf FI, Cittadini A. Magnesium in cell proliferation and differentiation. Front Biosci 1999; 4: D607-D617.
9. Rubin H. The logic of the Membrane, Magnesium, Mitosis (MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys 2007; 458: 16-23.
10. Fox C, Ramsoomair D, Carter C. Magnesium: Its proven and potential clinical significance. South Med J 2001; 94: 1195-1201.
11. Nozue T, Kobayashi A, Uemasu F, Takagi Y, Sako A, Endoh H. Magnesium status, serum HDL cholesterol, and apolipoprotein A-1 levels. J Pediatr Gastroenterol Nutr 1995; 20: 316-318.
12. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002; 39: 209-213.
13. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003; 24: 47-66.
14. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458: 40-47.
15. Sontia B, Touyz RM. Magnesium transport in hypertension. Pathophysiology 2007; 14: 205-211.
16. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II: Experimental aspects. Magnesium 1985; 4: 245-271.
17. Shechter M, Merz CN, Paul-Labrador M, Meisel SR, Rude RK, Molloy MD, et al. Oral magnesium supplementation inhibits platelet- dependent thrombosis in patients with coronary artery disease. Am J Cardiol 1999; 84: 152-156.
18. Laurant P, Touyz RM, Schiffrin EL. Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats. Can J Physiol Pharmacol 1997; 75: 293-300.
19. Touyz RM, Laurant P, Schiffrin EL. Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats. J Pharmacol Exp Ther 1998; 284: 998-1005.
20. 2+, PKC, and PI3. Am J Physiol Heart Circ Physiol 2000; 279: H2898-H2907.
21. e enhances arterial spontaneous tone via phosphatidylinositol 3-kinase in DOCA-salt hypertension. Hypertension 2004; 43: 125-129.
22. 2+ entry in vascular smooth muscle cells. Circulation 1997; 95: 2567-2572.
23. Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 2003; 114: 191-200.
24. Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 2003; 121: 49-60.
25. Schmitz C, Dorovkov MV, Zhao X, Davenport BJ, Ryazanov AG, Perraud AL. The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J Biol Chem 2005; 280: 37763-37771.
26. Romani AM. Regulation of magnesium homeostasis and transport in mammalian cells. Arch Biochem Biophys 2007; 458: 90-102.
27. Schlingmann KP, Waldegger S, Konrad M, Chubanov V, Gudermann T. TRPM6 and TRPM7: Gatekeepers of human magnesium metabolism. Biochim Biophys Acta 2007; 1772: 813-821.
28. Flatman PW, Smith LM. Magnesium transport in ferret red cells. J Physiol 1990; 431: 11-25.
29. +-dependent regulation of intracellular free magnesium concentration in isolated rat ventricular myocytes. J Mol Cell Cardiol 1996; 28: 1641-1651.
30. Okada K, Ishikawa S, Saito T. Cellular mechanisms of vasopressin and endothelin to mobilize [Mg2+]i in vascular smooth muscle cells. Am J Physiol 1992; 263: C873-C878.
31. Fagan TE, Romani A. Activation of Na(+)- and Ca(2+)-dependent Mg(2+) extrusion by alpha(1)- and beta-adrenergic agonists in rat liver cells. Am J Physiol Gastrointest Liver Physiol 2000; 279: G943-G950.
32. Romani AM, Maguire ME. Hormonal regulation of Mg2+ transport and homeostasis in eukaryotic cells. Biometals 2002; 15: 271-283.
33. Almulla HA, Bush PG, Steele MG, Ellis D, Flatman PW. Loading rat heart myocytes with Mg2+ using low-[Na+] solutions. J Physiol 2006; 575: 443-454.
34. Gunther T. Mechanisms, regulation and pathologic significance of Mg2+ efflux from erythrocytes. Magnes Res 2006; 19: 190-198.
35. Cefaratti C, Romani AM. Functional characterization of two distinct Mg(2+) extrusion mechanisms in cardiac sarcolemmal vesicles. Mol Cell Biochem 2007; 303: 63-72.
36. Bui DM, Gregan J, Jarosch E, Ragnini A, Schweyen RJ. The bacterial magnesium transporter CorA can functionally substitute for its putative homologue Mrs2p in the yeast inner mitochondrial membrane. J Biol Chem 1999; 274: 20438-20443.
37. Kolisek M, Zsurka G, Samaj J, Weghuber J, Schweyen RJ, Schweigel M. Mrs2p is an essential component of the major electrophoretic Mg2+ influx system in mitochondria. EMBO J 2003; 22: 1235-1244.
38. Goytain A, Quamme GA. Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties. BMC Genomics 2005; 6: 48.
39. Goytain A, Quamme GA. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters. Physiol Genomics 2005; 21: 337-342.
40. Goytain A, Quamme GA. Functional characterization of ACDP2 (ancient conserved domain protein), a divalent metal transporter. Physiol Genomics 2005; 22: 382-389.
41. Sahni J, Nelson B, Scharenberg AM. SLC41A2 encodes a plasmamembrane Mg2+ transporter. Biochem J 2007; 401: 505-513.
42. Goytain A, Hines RM, El-Husseini A, Quamme GA. NIPA1 (SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia encodes a functional Mg2+ transporter. J Biol Chem 2007; 282: 8060-8068.
43. Goytain A, Quamme GA. Identification and characterization of a novel family of magnesium transporters, MMgT1 and MMgT2. Am J Physiol Cell Physiol 2008; 294: C495-C502.
44. Goytain A, Hines RM, Quamme GA. Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions: Palmitoyl acyltransferase and Mg2+ transport. J Biol Chem 2008; 283: 33365-33374.
45. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999; 285: 103-106.
46. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31: 166-170.
47. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002; 31: 171-174.
48. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, et al. LTRPC7 is a Mg ATP-regulated divalent cation channel required for cell viability. Nature 2001; 411: 590-595.
49. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 2001; 291: 1043-1047.
50. Clapham DE, Montell C, Schultz G, Julius D. International Union of Pharmacology. International Union of Pharmacology. XLIII: Compendium of voltage-gated ion channels: Transient receptor potential channels. Pharmacol Rev 2003; 55: 591-596.
51. Kraft R, Harteneck C. The mammalian melastatin-related transient receptor potential cation channels: An overview. Pflugers Arch 2005; 451: 204-211.
52. Watanabe H, Murakami M, Ohba T, Ono K, Ito H. The pathological role of transient receptor potential channels in heart disease. Circ J 2009; 73: 419-427.
53. Ando J, Yamamoto K. Vascular Mechanobiology. Circ J 2009; 73: 1983-1992.
54. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 1998; 58: 1515-1520.
55. Grimm C, Kraft R, Sauerbruch S, Schultz G, Harteneck C, Goel M, et al. Molecular and functional characterization of the melastatinrelated cation channel TRPM3. J Biol Chem 2003; 278: 21493-21501.
56. Lee N, Chen J, Sun L, Wu S, Gray KR, Rich A, et al. Expression and characterization of human transient receptor potential melastatin 3 (hTRPM3). J Biol Chem 2003; 278: 20890-20897.
57. Zhang Y, Hoon MA, Chandrashekar J, Mueller KL, Cook B, Wu D, et al. Coding of sweet, bitter, and umami tastes: Different receptor cells sharing similar signaling pathways. Cell 2003; 112: 293-301.
58. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 2004; 95: 922-929.
59. Fonfria E, Murdock PR, Cusdin FS, Benham CD, Kelsell RE, McNulty S. Tissue distribution profiles of the human TRPM cation channel family. J Recept Signal Transduct Res 2006; 26: 159-178.
60. Schmitz C, Perraud AL, Fleig A, Scharenberg AM. Dual-function ion channel/protein kinases: Novel components of vertebrate magnesium regulatory mechanisms. Pediatr Res 2004; 55: 734-737.
61. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, et al. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 2001; 411: 595-599.
62. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, et al. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell 2002; 9: 163-173.
63. Monteilh-Zoller MK, Hermosura MC, Nadler MJS, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 2003; 121: 49-60.
64. van de Graaf SF, Bindels RJ, Hoenderop JG. Physiology of epithelial Ca2+ and Mg2+ transport. Rev Physiol Biochem Pharmacol 2007; 158: 77-160.
65. Chubanov V, Gudermann T, Schlingmann KP. Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. Pflugers Arch 2005; 451: 228-234.
66. Chubanov V, Schlingmann KP, Waring J, Heinzinger J, Kaske S, Waldegger S, et al. Hypomagnesemia with secondary hypocalcemia due to a missense mutation in the putative pore-forming region of TRPM6. J Biol Chem 2007; 282: 7656-7667.
67. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 2004; 279: 19-25.
68. Groenestege WM, Hoenderop JG, van den Heuvel L, Knoers N, Bindels RJ. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol 2006; 17: 1035-1043.
69. Groenestege WM, Thebault S, van der Wijst J, van den Berg D, Janssen R, Tejpar S, et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2007; 117: 2260-2267.
70. Thebault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 2009; 20: 78-85.
71. Ikari A, Sanada A, Okude C, Sawada H, Yamazaki Y, Sugatani J, et al. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. J Cell Physiol 2010; 222: 481-487.
72. Schrag D, Chung KY, Flombaum C, Saltz L. Cetuximab therapy and symptomatic hypomagnesemia. J Natl Cancer Inst 2005; 97: 1221-1224.
73. Tejpar S, Piessevaux H, Claes K, Piront P, Hoenderop JG, Verslype C, et al. Magnesium wasting associated with epidermal growthfactor receptor-targeting antibodies in colorectal cancer: A prospective study. Lancet Oncol 2007; 8: 387-394.
74. Cao G, van der Wijst J, van der Kemp A, van Zeeland F, Bindels RJ, Hoenderop JG. Regulation of the epithelial Mg2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA). J Biol Chem 2009; 284: 14788-14795.
75. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol 2006; 127: 525-537.
76. Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, Clapham DE. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science 2008; 322: 756-760.
77. Demeuse P, Penner R, Fleig A. TRPM7 channel is regulated by magnesium nucleotides via its kinase domain. J Gen Physiol 2006; 127: 421-434.
78. Yamaguchi H, Matsushita M, Nairn AC, Kuriyan J. Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol Cell 2001; 7: 1047-1057.
79. Penner R, Fleig A. The Mg2+ and Mg(2+)-nucleotide-regulated channel-kinase TRPM7. Handb Exp Pharmacol 2007; (179): 313-328.
80. Matsushita M, Kozak JA, Shimizu Y, McLachlin DT, Yamaguchi H, Wei FY, et al. Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1. J Biol Chem 2005; 280: 20793-20803.
81. Dorovkov MV, Ryazanov AG. Phosphorylation of annexin I by TRPM7 channel-kinase. J Biol Chem 2004; 279: 50643-50646.
82. Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG, Figdor CG, et al. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J 2006; 25: 290-301.
83. Su LT, Agapito MA, Li M, Simonson WT, Huttenlocher A, Habas R, et al. TRPM7 regulates cell adhesion by controlling the calcium- dependent protease calpain. J Biol Chem 2006; 281: 11260-11270.
84. Aarts MM, Tymianski M. TRPMs and neuronal cell death. Pflügers Arch 2005; 451: 243-249.
85. Sahni J, Scharenberg AM. TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. Cell Metab 2008; 8: 84-93.
86. Joffres MR, Reed DM, Yano K. Relation of magnesium intake and other dietary factors to blood pressure the Honolulu Heart Study. Am J Clin Nutr 1987; 45: 469-475.
87. Kesteloot H, Joossens JV. Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure: Belgian Interuniversity Research on Nutrition and Health. Circulation 1988; 12: 594-599.
88. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, et al. Prospective study of nutritional factors, blood pressure and hypertension among US women. Hypertension 1996; 27: 1065-1072.
89. Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, et al. Transient receptor potential channels in cardiovascular function and disease. Circ Res 2006; 99: 119-131.
90. Berthelot A, Esposito J. Effects of dietary magnesium supplementation on the development of hypertension in spontaneously hypertensive rat. J Am Coll Nutr 1983; 4: 343-353.
91. Touyz RM, Milne FJ. Magnesium supplementation attenuates, but does not prevent, the development of hypertension in spontaneously hypertensive rats. Am J Hypert 1999; 12: 757-765.
92. Ford ES. Race, education and dietary cations: Findings from the third national health and nutrition examination survey. Ethhnicity Dis 1998; 8: 10-20.
93. Barbagallo M, Gupta RK, Dominguez LJ, Resnick LM. Cellular ionic alterations with age: Relation to hypertension and diabetes. J Am Geriatr Soc 2000; 48: 1111-1116.
94. Laurant P, Berthelot A. Influence of endothelium on Mg2+-induced relaxation in noradrenaline-contracted aorta from DOCAsalt hypertensive rat. Eur J Pharmacol 1994; 258: 167-172.
95. Tammaro P, Smith AL, Crowley BL, Smirnov SV. Modulation of the voltage-dependent K+ current by intracellular Mg2+ in rat aortic smooth muscle cells. Cardiovasc Res 2005; 65: 387-396.
96. Yamaoka K, Seyama I. Regulation of Ca channel by intracellular Ca2+ and Mg2+ in frog ventricular cells. Pflügers Arch 1996; 431: 305-317.
97. Gilbert D'Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest 1992; 89: 1988-1994.
98. Yang Z, Wang J, Altura BT, Altura BM. Extracellular magnesium deficiency induces contraction of arterial muscle: Role of PI3-kinases and MAPK signaling pathways. Pflugers Arch 2000; 439: 240-247.
99. Altura BM, Altura BT, Carella A. Magnesium deficiency-induced spasms of umbilical vessels: Relation to preeclampsia, hypertension, growth retardation. Science 1983; 221: 376-378.
100. Kisters K, Barenbrock M, Louwen F, Hausberg M, Rahn KH, Kosch M. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia. Am J Hypertens 2000; 13: 765-769.
101. Laurant P, Berthelot A. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: Effect of magnesium. Br J Pharmacol 1996; 119: 1367-1374.
102. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium- deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992; 110: 169-173.
103. Touyz RM, Pu Q, He G, Chen X, Yao G, Neves MF, et al. Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: Role of reactive oxygen species. J Hypertens 2002; 20: 2221-2232.
104. Gueux E, Azais-Braesco V, Bussiere L, Grolier P, Mazur A, Rayssiguier Y. Effect of magnesium deficiency on triacylglycerolrich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. Br J Nutr 1995; 74: 849-856.
105. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70: 593-599.
106. Malpuech-Brugere C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000; 1501: 91-98.
107. Gilles-Baillien M, Cogneau M. Mg2+ uptake by intestinal brushborder membrane of spontaneously hypertensive rats. Proc Soc Exp Biol Med 1992; 201: 119-124.
108. Gunther T. Na+/Mg2+ antiport in non-erythrocyte vertebrate cells. Mag Res 2007; 20: 89-99.
109. Touyz RM, Schiffrin EL. Activation of the Na+/H+ exchanger modulates angiotensin II stimulated Na+-dependent Mg2+ transport in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 1999; 34: 442-449.
110. Touyz RM, Yao G. Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21: 337-344.
111. Touyz RM, Yao G. Up-regulation of vascular and renal mitogenactivated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger. Clin Sci (Lond) 2003; 105: 235-242.
112. Gurney AM. Going with the flow: Smooth muscle TRPM7 channels and the vascular response to blood flow. Circ Res 2006; 98: 163-164.
113. Paravicini TM, Yogi A, Mazur A, Touyz RM. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009; 53: 423-429.
114. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: Role of angiotensin II. Circ Res 2005; 96: 207-215.
115. Touyz RM, He Y, Montezano AC, Yao G, Chubanov V, Gudermann T, et al. Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by Ang II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R73-R78.
116. Sontia B, Montezano AC, Paravicini T, Tabet F, Touyz RM. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: Effects of magnesium. Hypertension 2008; 51: 915-921.
117. Oancea E, Wolfe JT, Clapham DE. Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ Res 2006; 98: 245-253.
118. Yogi A, Callera GE, Tostes R, Touyz RM. Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells. Am J Physiol Regul Integr Comp Physiol 2009; 296: R201-R207.
119. Ameen M, Davies JE, Ng LL. A comparison of free intracellular calcium and magnesium levels in the vascular smooth muscle and striated muscle cells of the spontaneously hypertensive and Wistar Kyoto normotensive rat. Ann New York Acad Sci 1991; 639: 550-553.
120. Adachi M, Nara Y, Mano M, Ikeda K, Horie R, Yamori Y. Intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats and effects of blood pressure and various antihypertensive agents. Clin Exp Pharmacol Physiol 1993; 20: 587-593.
121. Henrotte JG, Franck G, Santarromana M, Frances H, Mouton D, Motta R. Mice selected for low and high blood magnesium levels: A new model for stress studies. Physiol Behav 1997; 61: 653-658.
122. Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, et al. Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation 2002; 74: 784-791.
123. Runyan AL, Sun Y, Bhattacharya SK, Ahokas RA, Chhokar VS, Gerling IC, et al. Responses in extracellular and intracellular calcium and magnesium in aldosteronism. J Lab Clin Med 2005; 146: 76-84.
124. Fiebeler A, Muller DN, Shagdarsuren E, Luft FC. Aldosterone, mineralocorticoid receptors, and vascular inflammation. Curr Opin Nephrol Hypertens 2007; 16: 134-142.
125. Delva P, Pastori C, Degan M, Montesi G, Brazzarola P, Lechi A. Intralymphocyte free magnesium in patients with primary aldosteronism: Aldosterone and lymphocyte magnesium homeostasis. Hypertension 2000; 35: 113-117.
126. Gao X, Peng L, Adhikari CM, Lin J, Zuo Z. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail 2007; 13: 170-177.